"Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: High-Risk injection behaviors in Tijuana, Mexico

Journal of Urban Health

Volumn 82, Issue SUPPL. 4, 2005, Pages

  Strathdee, Steffanie A ^a,e   Fraga, Wendy Davila ^b   Case, Patricia ^c   Firestone, Michelle ^a   Brouwer, Kimberly C ^a   Perez, Saida Gracia ^a   Magis, Carlos ^d   Fraga, Miguel Angel ^b  

^a University of California School of Medicine   (United States)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SECRETARÍA DE SALUD   (Mexico)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Border; HIV AIDS; Injection drug use; Mexico; Needle exchange programs; Pharmacies

Indexed keywords

DIAMORPHINE; METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEXICO; NEEDLE; PRIORITY JOURNAL; RESEARCH; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; BEHAVIORAL RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; INTERVIEWS; LAW ENFORCEMENT; MALE; MEXICO; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 26644444802     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1093/jurban/jti108     Document Type: Conference Paper

References (44)

1. INEGI (Instituto Nacional de Estadistica, Geografia e Informatica). Preliminary Results for the XII National Population and Housing Census-2000. (Resultados Preliminares del XII Censo Nacional de Población y Vivienda 2000). México, Distrito Federal, 2000.
2. COPLADEM (Comité de Planeación para el Desarrollo del Estado de México) Plan Municipal de Desarrollo 1996-1998, Tijuana. SDSU Institute for Regional Studies of the Californias. Available at: http://www-rohan.sdsu.edu/~irsc/tjreport/tj9.html. Accessed April 15, 2005.
3. SDSU Institute for Regional Studies of the Californias. Available at: http://www-rohan.sdsu.edu/~irsc/tjreport/tj3.html. Accessed April 15, 2005.
4. Lange JE, Lauer EM, Voas RB. A survey of the San Diego-Tijuana cross-border binging. Eval Rev. 1999;23:378-398.
5. Huntington SP. The Hispanic challenge. Foreign Policy [serial online]. Available at: http://www.foreignpolicy.com/story/cms.php?story_id=2495. Accessed June 30, 2004.
6. Central Intelligence Agency. The world factbook. Available at: http://www.cia.gov/cia/publications/factbook/. Accessed March 10, 2005.
7. Drug Enforcement Administration. Mexico: country profile for 2003. Drug Intelligence Report DEA-03047. Available at: http://www.usdoj.gov/dea/pubs/ intel/03047/03047.pdf. Accessed July 12, 2004.
8. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 2000;14:75-83.
9. Adelekan ML, Stimson GV. Problems and prospects of implementing harm reduction for HIV and injecting drug use in high risk sub-Saharan African countries. J Drug Issues. 1997;27:97-116.
10. Bastos FI, Strathdee SA, Derrico M, Pina MDF. Drug abuse and the spread of HIV/AIDS in South America and the Caribbean. Drugs Educ Prev Policy. 1999;6:29-50.
11. Bucardo J, Brouwer KC, Magis C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug and Alcohol Dependence. In press.
12. Magis-Rodriguez C, Ruiz-Badillo A, Ortiz-Mondragon R, Loya-Sepulveda M, Bravo-Portela MJ, Lozada R. Estudio sobre prácticas de riesgo de infección para VIH/SIDA en inyectores de drogas de la cd. de Tijuana B.C. Biblioteca Virtual en Salud [serial online]. 2002. Available at: http://bvs.insp.mx/componen/svirtual/ppriori/09/0399/arti.htm. Accessed July 25, 2004.
13. Secretaria de Salud, Consejo Nacional Contra las Adicciones (SSA-CONADIC). Encuesta Nacional de Adicciones 1999. Available at: http://www.salud.gob.mx/unidades/conadic/epidem.htm. Accessed February 14, 2004.
14. Morales S, Lozada R, Magis C, Saavedra JA, Monitoreo. Evaluation of HIV prevention interventions in injectable drug users in Mexico. In: XV International Conference on AIDS; July 11-17, 2004; Bangkok, Thailand.
15. UNAIDS. Report on the Global HIV/AIDS Epidemic, 2002. July 2002; Geneva, Switzerland.
16. CONASIDA. Panorama Epidemiológico del VIH/SIDA e ITS en México [Epidemiologic overview of HIV/AIDS and STD in México]. Available at: http://www.salud.gob.mx/conasida/comite/minutas/cua20020.pdf. Accessed October 29, 2002.
17. Magis-Rodríguez C, Bravo-García E, Rivera Reyes P. El sida en México en el año 2000. In: Uribe, P, Magis, C, eds. La Respuesta Mexicana Al SIDA: Mejores Prácticas. México: Ángulos Del SIDA. Mexico, Distrito Federal: Consejo Nacional para la Prevencion y Control del SIDA; 2000:13-22.
18. Viani RM, Hubbard P, Araneta MR, et al. Pregnant women in Baja California, Mexico: evidence of an emerging crisis? XV International Conference on AIDS; July 11-17, 2004; Bangkok, Thailand.
19. Magis C, Brouwer KC, Morales S, et al. Correlates of receptive needle sharing among injection drug users (IDUs) in the US-Mexican border city of Tijuana. In:3rd International Conference on Urban Health; October 20-22, 2004; Boston, MA.
20. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.
21. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51:1771-1782.
22. Des J, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226-1231.
23. Emerson R. Producing ethnographies: theory, evidence and representation. In: Emerson, R, ed. Contemporary Field Research. Prospect Heights, IL: Waveland Press; 2001: 295-296.
24. Watters JK, Biernacki P. Targeted sampling, options for the study of hidden populations. Soc Probl. 1989;36:416-430.
25. Greenfield L, Bigelow GE, Brooner RK. HIV risk behavior in drug users: increased blood "booting" during cocaine injection. AIDS Educ Prev. 1992;4:95-107.
26. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994-1002.
27. Rhodes T, Mikhailova LA, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57:39-54.
28. Burris S, Lurie P, Abrahamson D, Rich JD. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Ann Intern Med. 2000;133:218-226.
29. Case PL, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possesion in Massachusetts: implications for HIV prevention. J Acquir Immune Defic Syndr. 1998;18:S71-S75.
30. Case PL, Beckett GA, Jones TS. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. J Acquir Immune Defic Syndr. 1998;18:S94-S101.
31. Taussig JA, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14:S47-S51.
32. Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc (Wash). 2002;42:S52-S57.
33. Celentano D, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81:1291-1295.
34. Page JB, Smith PC, Kane N. Shooting galleries, their proprietors, and implications for prevention of AIDS. Drugs Soc. 1990;5:69-85.
35. Robles RR, Marrero CA, Reyes JC, et al. Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. J Acquir Immune Defic Syndr. 1998;17:477-483.
36. Garfein RS, Monterroso E, Tong TC, et al. Comparison of HIV infection risk behaviors among injection drug users from east and west coast US cities. J Urban Health. 2004;81:260-267.
37. Burris S, Blankenship KM, Donoghoe M, et al. Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82:125-156.
38. Koester S. Copping, running and paraphernalia laws: contextual and needle risk behaviors among drug users in Denver. Human Organ. 1994;53:287-295.
39. Strathdee SA, Zafar T, Brahmbhatt H, Baksh A, ul Hassan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003;71:17-24.
40. Harvey E, Strathdee SA, Patrick DM, et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 1998;10:313-321.
41. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti city, Russia. AIDS. 2002;16:25-31.
42. Bardach E. The Implementation Game: What Happens After a Bill Becomes Law. Cambridge, MA: MIT Press; 1997.
43. Percy SL. Disability, Civil Rights, and Public Policy: The Politics of Implementation. Tuscaloosa, AL: University of Alabama Press; 1989.
44. Galea S, Ahern J, Vlahov D. Contextual determinants of drug use risk behavior: a theoretic framework. J Urban Health. 2003;80:50-58.